Lu Wang

Dr. Lu Wang


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 December 2022 in Biomedicines
Verified
Journal Article
Open access
PDF file
ZHZengshu Huang
Zengshu Huang
ZTZHIJING TANG
ZHIJING TANG
HGHaiyun Guan
Haiyun Guan
WLWingting Leung
Wingting Leung
LWLu Wang
Lu Wang
WZWei Zhang
Wei Zhang
Pregnancy morbidity induced by anti-phospholipid antibodies (aPL+/PM+) is mainly thought to arise from placental abnormalities. We attempted to investigate the effect of aPL on the activity of Yes-associated protein (YAP) in the trophoblast and how YAP regulated human trophoblasts function. Thus, HTR-8 cells were treated with IgG purified from aPL+/PM+ women or normal controls. We found that aPL+/PM+ IgG impacted YAP activity via abrogating YAP expression. Further investigation of the anti-β2GPI-IgG/β2GPI complex showed an inhibition of nuclear YAP level and translocation in a dose-dependent manner, which might be rescued by progesterone in HTR-8 cells. YAP overexpression or knockdown HTR-8 cells were established for the evaluation of cell function and related gene expression in vitro. Loss of YAP arrested cell cycles in the G2/M phase, accelerated cell apoptosis by increasing the ratio of Bax/Bcl2, and disrupted MMP2/9-mediated cell migration and angiogenesis tube formation by VEGF. These findings support a new mechanism of PM associated with aPL through which YAP inactivation induced by aPL perturbs the trophoblast cell cycle, apoptosis, migration, and angiogenesis, finally developing into pregnancy failure.

29 September 2026 in Biomedicines
Verified
Journal Article
Open access
PDF file
LWLu Wang
Lu Wang
ZTZhijing Tang
Zhijing Tang
HZHao Zhu
Hao Zhu
HYHailin Yu
Hailin Yu
XXXiaohong Xue
Xiaohong Xue
WZWei Zhang
Wei Zhang
Background: Polyendocrine metabolic ovarian syndrome (PMOS), previously known as polycystic ovary syndrome (PCOS), is a prevalent endocrine disorder increasingly associated with mild cognitive impairment (MCI). Mitochondrial dysfunction and immune dysregulation may underlie this association; however, shared molecular features between these conditions remain systematically uninvestigated. Methods: We used PMOS (granulosa cell, n = 16) and MCI (peripheral blood, n = 243) to identify differentially expressed genes (DEGs) intersecting mitochondrial-related genes (MRGs), supported by enrichment and prioritized by machine-learning with cross-validation. Boxplots in PMOS and MCI confirmed directionality. Single-cell RNA sequencing (scRNA-seq) identified cell types and communication. In vitro experiments assessed SCO2, LYN, and FGR in cell lines. Results: We identified 16 mitochondrial-related genes shared by PMOS and MCI datasets. Enrichment implicated NF-κB and TNF signaling in PMOS/MCI immunometabolic features. SCO2, LYN, and FGR were upregulated across datasets, although LYN was discordant in granulosa comparison. Single-cell sequencing identified five subtypes. Pseudotime showed SCO2 and LYN upregulation in early/late stages, whereas FGR was undetectable. Secondary annotation identified plasmacytoid dendritic cells, classical monocytes, and pro-B cells; pro-B cells predominated in controls (47.5%) and classical monocytes in disease (40.5%). In vitro validation showed mRNA/protein upregulation of SCO2, LYN, and FGR in PMOS/MCI models versus control. Conclusions: This study identified SCO2, LYN, and FGR as mitochondria-associated immune-inflammatory signatures in PMOS and MCI datasets. Differential expression, feature-ranking models, pathway enrichment, transcriptional deconvolution, single-cell contextualization, and cell assessment support were utilized. Without PMOS–MCI cohorts and functional perturbation experiments, findings remain hypothesis-generating, unvalidated biomarkers or causal mechanisms.